Superworth

Large drugmakers with the highest free cash flow yield

Free cash flow over the last twelve months as a share of market value. As of .

Ranked
41
of 411 large drugmakers we cover
Median
5.4%
Highest
26.0%
EBS
Range
0.0% to 26.0%
median 5.4%
0.0%26.0%
#CompanyFCF yieldPERevenue growth (TTM)Market cap
1EBSEmergent BioSolutions26.0%n/m−17.7%$330.2M
2ORGOOrganogenesis21.4%n/m+6.5%$97.2M
3AKBAAkebia Therapeutics20.5%n/m+7.5%$196.3M
4OGNOrganon18.6%18.2×−3.2%$3.6B
5AYTUAytu Biopharma15.4%n/m−13.3%$21.1M
6AMPHAmphastar Pharmaceuticals13.3%15.9×+1.0%$1.1B
7NRIXNurix Therapeutics13.2%11.1×n/m$2.8B
8INVAInnoviva12.5%n/m+18.8%$1.5B
9PCRXPacira BioSciences12.4%104×+5.7%$1.5B
10JAZZJazz Pharmaceuticals11.4%14.7×+12.6%$13.9B
11ANIPANI Pharmaceuticals10.7%15.0×+30.9%$1.6B
12PBHPrestige Consumer Healthcare10.0%13.9×−1.4%$2.4B
13LFVNLifevantage9.1%14.7×−20.1%$73.5M
14NATRNatures Sunshine Products8.6%11.9×+6.8%$211.5M
15PBYIPuma Biotechnology7.8%19.6×−2.9%$525.5M
16BIIBBiogen7.3%44.3×+0.3%$37B
17BMRNBiomarin Pharmaceutical6.6%155×+11.2%$11.1B
18PFEPfizer6.2%40.6×−0.2%$176B
19RMTIRockwell Medical5.5%n/m−21.1%$27.9M
20PRGOPERRIGO5.5%n/m−4.2%$2.2B
21ZVRAZevra Therapeutics5.4%10.9×+119.4%$599.8M
22SEPNSepterna5.2%n/mn/m$2B
23ACADAcadia Pharmaceuticals4.1%n/m+11.8%$3.5B
24SUPNSupernus Pharmaceuticals4.1%n/m+26.9%$2.1B
25AMGNAmgen4.0%29.0×+9.1%$252.3B
26LQDALiquidia4.0%30.1×n/m$3.7B
27ELANElanco Animal Health3.1%n/m+12.0%$12B
28ALKSAlkermes plc.2.9%118×+10.8%$7.5B
29KNSAKiniksa Pharmaceuticals International2.6%93.6×+58.9%$7.1B
30LGNDLigand Pharmaceuticals2.1%32.7×+54.9%$6.1B
31AMRXAmneal Pharmaceuticals2.0%41.7×+9.3%$6.5B
32PTGXProtagonist Therapeutics1.4%135×+34.8%$9B
33CORTCorcept Therapeutics1.2%192×+16.0%$8.7B
34CPIXCumberland Pharmaceuticals1.1%n/m−1.1%$63.2M
35ETONEton Pharmaceuticals1.0%n/mn/m$1.5B
36ARQTArcutis Biotherapeutics1.0%142×+76.1%$3.9B
37INDVIndivior Pharmaceuticals0.7%10.2×+16.3%$4.3B
38PAHCPhibro Animal Health0.6%15.9×+17.1%$1.6B
39HROWHarrow0.5%n/m+21.1%$1.1B
40TGTXTG Therapeutics0.2%21.9×+76.1%$9.2B
41PTCTPTC Therapeutics0.0%n/m−35.1%$5.1B

Not ranked: 167 with no positive free cash flow, 111 with not a meaningful number, 3 with a yield above 40% (usually a one-off). 89 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

FCF yield for other groups

Other rankings of large drugmakers

The group